AAN Presents Ethical Considerations Relating to Dementia Care
Timely anticipatory planning in early dementia is crucial to preserve autonomy over future decisions and to reduce caregiver strain
High-Efficacy Therapy May Reduce Relapses in Active SPMS
But no difference in disability progression seen for high-efficacy versus low-efficacy therapy for secondary progressive multiple sclerosis
Medicare Mulls Coverage for Controversial Drug for Alzheimer Disease
CMS says a final decision on coverage is not likely until next spring
Longer Reproductive Window Could Up Risk for Alzheimer Disease
Authors suggest longer exposure to endogenous estrogen may be associated with increased levels of Alzheimer disease biomarkers
Nearly Four in 10 With Mild COVID-19 Report Symptoms Seven Months Later
Fatigue remains the most common symptom among otherwise healthy people
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered
FDA Head Asks for Investigation Into Alzheimer Disease Drug Approval
Request follows reports that Biogen and the FDA held off-the-books meetings before the drug's approval that may have violated FDA protocol
Reading Problems in Childhood Tied to Poorer Memory Scores in Adulthood
Reading problems also linked to poorer Addenbrooke's Cognition Examination scores at age 69 years, which were partially mediated by education
Benefit, Safety of Muscle Relaxants for Low Back Pain Uncertain
Findings based on large literature review and meta-analysis
Tooth Loss May Up Risk for Cognitive Decline, Dementia
Dose-response relationship demonstrated between the number of missing teeth and risk for cognitive decline
